Apeloa Pharmaceutical Co.,Ltd (SHE:000739)

China flag China · Delayed Price · Currency is CNY
18.17
-0.38 (-2.05%)
Feb 13, 2026, 3:04 PM CST
Market Cap20.87B +18.7%
Revenue (ttm)10.50B -14.4%
Net Income861.74M -19.7%
EPS0.75 -19.0%
Shares Out1.15B
PE Ratio24.37
Forward PE14.54
Dividend0.35 (1.92%)
Ex-Dividend DateSep 17, 2025
Volume6,005,474
Average Volume10,445,366
Open18.55
Previous Close18.55
Day's Range18.17 - 18.85
52-Week Range12.96 - 19.59
Beta0.41
RSI50.27
Earnings DateMar 20, 2026

About SHE:000739

Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally. It operates through API, CDMO, and Pharmaceutical segments. The company offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates series; innovative drug R&D and production services CDMO include R&D services, commercial human drug projects, commercial veterinary drug projects and other... [Read more]

Sector Healthcare
Founded 1989
Employees 7,060
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000739
Full Company Profile

Financial Performance

In 2024, SHE:000739's revenue was 12.02 billion, an increase of 4.77% compared to the previous year's 11.47 billion. Earnings were 1.03 billion, a decrease of -2.29%.

Financial Statements